The purpose of this study is to compare intensive and standard training for human insulin inhalation powder in patients with type 2 diabetes.

Condition	Treatment or Intervention	Phase
Diabetes Mellitus, Type 2	Drug: HIIP treatment	Phase II

Further Study Details: 

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Type 2 diabetes for at least 12 months
• Age 18 or older.
• Taking at least 1 oral antihyperglycemic medication.
• Have an HbA1C between 7.5 and 12.
• Be a nonsmoker

Exclusion Criteria:

• Body Mass Index (BMI) greater than 40.
• Have frequent episodes of severe hypoglycemia.
• Have advanced autonomic neuropathy.
• Have history of asthma.
• Have chronic obstructive pulmonary disease (COPD).

California
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., San Diego,  California,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., San Mateo,  California,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Walnut Creek,  California,  United States
Colorado
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Denver,  Colorado,  United States
Florida
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Hollywood,  Florida,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., New Port Richey,  Florida,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., West Palm Beach,  Florida,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Clearwater,  Florida,  United States
Georgia
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Atlanta,  Georgia,  United States
Idaho
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Idaho Falls,  Idaho,  United States
Illinois
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Springfield,  Illinois,  United States
Maryland
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Baltimore,  Maryland,  United States
Mississippi
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Jackson,  Mississippi,  United States
Missouri
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Chesterfield,  Missouri,  United States
Nebraska
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Omaha,  Nebraska,  United States
New Hampshire
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Hampton,  New Hampshire,  United States
New York
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Flushing,  New York,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., New Hyde Park,  New York,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., New York,  New York,  United States
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Buffalo,  New York,  United States
Texas
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Dallas,  Texas,  United States
Washington
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Renton,  Washington,  United States
Argentina, Rosario
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Sante Fe,  Rosario,  Argentina
Canada, Ontario
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician., Toronto,  Ontario,  Canada
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician., Mississauga,  Ontario,  Canada
Canada, Quebec
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician., St Jerome,  Quebec,  Canada
Portugal
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., Norway,  Portugal
South Africa
      For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CT Lilly (1-877-285-4559) or speak with your personal physician., George,  South Africa

Study ID Numbers:  9523
Record last reviewed:  April 2005
Last Updated:  April 7, 2005
Record first received:  December 15, 2004
ClinicalTrials.gov Identifier:  NCT00099515
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08